Sarah A. Morrow, MD, FRCPC, MS

Sarah-Morrow_115x150.jpg Associate Professor of Neurology, Western University
Office: London Health Sciences Centre, University Hospital B10-133
Phone: 519-663-2993
Secretary: Ashley MacLean

 

 

 Bio Sketch

Dr. Morrow is an Associate Professor in the Department of Clinical Neurological Sciences at Western University (London, ON) and Director of the London (ON) MS Clinic.

She received her MD from the University of Calgary and completed her residency training in neurology at Western University. This was followed by a clinical fellowship in MS at the London MS clinic at Western University and a research fellowship on Cognition and MS with Dr. Ralph Benedict, a neuropsychologist, at the Jacobs Neurologic Institute in Buffalo NY. Dr. Morrow has also completed a Master's of Science in Epidemiology at the State University of New York at Buffalo. 

In addition to her clinical work in the London MS clinic, she established the first MS Cognitive clinic in Canada located at Parkwood Institute. She is a Board member for the Consortium of MS Centers and on the editorial board of both the International Journal of MS care and the Canadian Journal of Neurological Sciences. She is on the steering committee of the International MS Cognition Society and of MS in the 21st Century, an international collaboration with the aim of defining how MS treatment and standard of care should look in the 21st century. She currently has over 100 peer-reviewed publications in the area of MS.

Research

Cognitive Dysfunction in MS, Corticosteroid Treatment for MS


Medical Interests

Multiple Sclerosis and related diseases


Honours and Awards

  • 2019, Dr. Joseph Gilbert Research Contribution of the Year Award, Dr. Joseph Gilbert Research Contribution of the Year Award. Awarded for “Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs. Intravenous Corticosteroids: A Randomized Clinical Trial,” published in JAMA Neurology in June 2018, considered to be a stellar contribution to research with significant clinical relevance and impact. Type: Research award, International, Neurology - Multiple Sclerosis

  • 2017, Lawson Impact Award, Lawson Impact Award for Lawson Strategic Research Fund. Awarded, with co-investigator Dr. Arlene MacDougall, for a mindfulness intervention project to help newly diagnosed persons with MS cope with the diagnosis, Type: Research award, Provincial, Neurology - Multiple Sclerosis

  • 2010, Young Investigaros Award, ECTRIMS

Publications

PubMed Publications Listing

Publications

Mackay L, Johnson AM, Moodie ST, Rosehart H, Morrow SA Predictors of cognitive fatigue and fatigability in multiple sclerosis. Mult Scler Relat Disord. 2021 Oct 7;56:103316. doi: 10.1016/j.msard.2021.103316. Epub ahead of print. PMID: 34638096.

Baldwin C, Morrow SA. Do isolated cognitive relapses exist? - No. Mult Scler. 2021 Sep;27(10):1488-1489. doi: 10.1177/13524585211014459. Epub 2021 Aug 19. PMID: 34410172.

Hue CD, Bullrich MB, Lam Shin Cheung VC, Sharma AK, Syed AS, Pandey SK, Morrow SA, Debicki DB. Pearls & Oy-sters: Trigeminal Nerve Dysfunction as the Key Diagnostic Clue to Listeria Rhombencephalitis. Neurology. 2021 May 26:10.1212/WNL.0000000000012273. doi: 10.1212/WNL.0000000000012273. Epub ahead of print. PMID: 34039730.

Morrow SA, Riccio P, Vording N, Rosehart H, Casserly C, MacDougall A. A mindfulness group intervention in newly diagnosed persons with multiple sclerosis: A pilot study. Mult Scler Relat Disord. 2021 Jul;52:103016. doi: 10.1016/j.msard.2021.103016. Epub 2021 May 8. PMID: 34020388.

Giacomini PS, Oh J, Morrow SA, Beauchemin P, Clift F, Devonshire V. Videoconferencing and Multiple Sclerosis Management: Stopgap or Stay Tuned? Can J Neurol Sci. 2021 May 17:1-4. doi: 10.1017/cjn.2021.113. Epub ahead of print. PMID: 33998416.

Krasniuk S, Classen S, Morrow SA. Driving errors that predict simulated rear-end collisions in drivers with multiple sclerosis. Traffic Inj Prev. 2021;22(3):212-217. doi: 10.1080/15389588.2021.1883008. Epub 2021 Mar 10. PMID: 33688770.

Krasniuk S, Classen S, Morrow SA, Alvarez L, He W, Srinivasan S, Monahan M. Clinical predictors of driving simulator performance in drivers with multiple sclerosis. Mult Scler. 2021 Nov;27(13):2085-2092. doi: 10.1177/1352458521992507. Epub 2021 Feb 10. PMID: 33565905.

Blair M, Goveas D, Safi A, Marshall C, Rosehart H, Orenczuk S, Morrow SA. Does cognitive training improve attention/working memory in persons with MS? A pilot study using the Cogmed Working Memory Training program. Mult Scler Relat Disord. 2021 Apr;49:102770. doi: 10.1016/j.msard.2021.102770. Epub 2021 Jan 17. PMID: 33497850.

Morrow SA, Conway D, Fuchs T, Wojcik C, Unverdi M, Yasin F, Pol J, Eckert S, Hojnacki DH, Dwyer M, Zivadinov R, Weinstock-Guttman B, Benedict RH. Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses. Mult Scler. 2021 Jun;27(7):1077-1087. doi: 10.1177/1352458520973618. Epub 2020 Dec 1. PMID: 33259273.

Saslow L, Li DKB, Halper J, Banwell B, Barkhof F, Barlow L, Costello K, Damiri P, Dunn J, Giri S, Maes M, Morrow SA, Newsome SD, Oh J, Paul F, Quarterman P, Reich DS, Shewchuk JR, Shinohara RT, Van Hecke W, van de Ven K, Wallin MT, Wolinsky JS, Traboulsee A. An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies. Int J MS Care. 2020 Sep-Oct;22(5):226-232. doi: 10.7224/1537-2073.2020-094. Epub 2020 Oct 27. PMID: 33177959; PMCID: PMC7643842.

Alshamrani F, Berger W, Alnajashi H, Payne MWC, Morrow SA. Potential of Timed 25-Foot Walk Values in Predicting Maximum Walking Distance in Persons with Multiple Sclerosis. Int J MS Care. 2020 Sep-Oct;22(5):215-218. doi: 10.7224/1537-2073.2019-052. Epub 2020 Jan 13. PMID: 33177957; PMCID: PMC7643844.

Shosha E, Casserly C, Tomkinson C, Morrow SA. Blood pressure changes during alemtuzumab infusion for multiple sclerosis patients. Eur J Neurol. 2021 Apr;28(4):1396-1400. doi: 10.1111/ene.14633. Epub 2020 Dec 5. PMID: 33175474.

Abel S, Vavasour I, Lee LE, Johnson P, Ristow S, Ackermans N, Chan J, Cross H, Laule C, Dvorak A, Schabas A, Hernández-Torres E, Tam R, Kuan AJ,Morrow SA, Wilken J, Rauscher A, Bhan V, Sayao AL, Devonshire V, Li DKB, Carruthers R, Traboulsee A, Kolind SH. Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis. JAMA Netw Open. 2020 Sep 1;3(9):e2014220. doi: 10.1001/jamanetworkopen.2020.14220. PMID: 32990740; PMCID: PMC7525360.

Tomkinson C, Dresser GK, Renn R, Morrow SA. The effects of high-dose corticosteroids for multiple sclerosis relapse on blood pressure: A pilot study. Mult Scler Relat Disord. 2020 Oct;45:102401. doi: 10.1016/j.msard.2020.102401. Epub 2020 Jul 15. PMID: 32702644.

Freedman MS, Devonshire V, Duquette P, Giacomini PS, Giuliani F, Levin MC, Montalban X, Morrow SA, Oh J, Rotstein D, Yeh EA; Canadian MS Working Group. Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations. Can J Neurol Sci. 2020 Jul;47(4):437-455. doi: 10.1017/cjn.2020.66. Epub 2020 Apr 6. PMID: 32654681.

Bagnato F, Gauthier SA, Laule C, Moore GRW, Bove R, Cai Z, Cohen-Adad J, Harrison DM, Klawiter EC, Morrow SA, Öz G, Rooney WD, Smith SA, Calabresi PA, Henry RG, Oh J, Ontaneda D, Pelletier D, Reich DS, Shinohara RT, Sicotte NL; NAIMS Cooperative. Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy. J Neuroimaging. 2020 May;30(3):251-266. doi: 10.1111/jon.12700. PMID: 32418324. 

Alshamrani F, Alnajashi H, Shosha E, Casserly C, Morrow SA. Case Series: Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Related Disease Spectrum. Front Neurol. 2020 Feb 26;11:89. doi: 10.3389/fneur.2020.00089. PMID: 32174880; PMCID: PMC7055463.

Povolo CA, Reid JN, Shariff SZ, Welk B, Morrow SA. Concussion in adolescence and the risk of multiple sclerosis: A retrospective cohort study. Mult Scler. 2021 Feb;27(2):180-187. doi: 10.1177/1352458520908037. Epub 2020 Feb 24. PMID: 32091315.

Son M, McEwan L, Ubaidat M, Bovell K, Morrow SA. Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis. Mult Scler. 2020 Nov;26(13):1801-1803. doi: 10.1177/1352458519900961. Epub 2020 Feb 7. PMID: 32031458.

Benedict RH, Pol J, Yasin F, Hojnacki D, Kolb C, Eckert S, Tacca B, Drake A, Wojcik C, Morrow SA, Jakimovski D, Fuchs TA, Dwyer MG, Zivadinov R, Weinstock-Guttman B. Recovery of cognitive function after relapse in multiple sclerosis. Mult Scler. 2021 Jan;27(1):71-78. doi: 10.1177/1352458519898108. Epub 2020 Jan 23. PMID: 31971066.

Abel S, Vavasour I, Lee LE, Johnson P, Ackermans N, Chan J, Dvorak A, Schabas A, Wiggermann V, Tam R, Kuan AJ, Morrow SA, Wilken J, Laule C, Rauscher A, Bhan V, Sayao AL, Devonshire V, Li DK, Carruthers R, Traboulsee A, Kolind SH. Myelin Damage in Normal Appearing White Matter Contributes to Impaired Cognitive Processing Speed in Multiple Sclerosis. J Neuroimaging. 2020 Mar;30(2):205-211. doi: 10.1111/jon.12679. Epub 2019 Nov 24. PMID: 31762132.

Povolo CA, Blair M, Mehta S, Rosehart H, Morrow SA. Predictors of vocational status among persons with multiple sclerosis. Mult Scler Relat Disord. 2019 Nov;36:101411. doi: 10.1016/j.msard.2019.101411. Epub 2019 Sep 26. PMID: 31586801.

Luhoway JA, Sharma M, Menon S, Rosehart H, Morrow SA. Posterior Fossa Lesion Load and Pathological Laughing and Crying in Multiple Sclerosis. Int J MS Care. 2019 May-Jun;21(3):135-142. doi: 10.7224/1537-2073.2018-016. PMID: 31191179; PMCID: PMC6552995.

Riccio PM, Fraser JA, Lee DH, Morrow SA. Severe sequential visual loss in MS co-diagnosis of Leber's hereditary optic neuropathy. Can J Ophthalmol. 2019 Apr;54(2):e69-e70. doi: 10.1016/j.jcjo.2018.06.020. Epub 2018 Aug 30. PMID: 30975365. 

Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH. Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial. BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3. PMID: 30738426; PMCID: PMC6368728.

Krasniuk S, Classen S, Morrow SA, Tippett M, Knott M, Akinwuntan A. Clinical Determinants of Fitness to Drive in Persons With Multiple Sclerosis: Systematic Review. Arch Phys Med Rehabil. 2019 Aug;100(8):1534-1555. doi: 10.1016/j.apmr.2018.12.029. Epub 2019 Jan 26. PMID: 30690007.

Grand'Maison F, Yeung M, Morrow SA, Lee L, Emond F, Ward BJ, Laneuville P, Schecter R. Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches. Neural Regen Res. 2018 Nov;13(11):1871-1874. doi: 10.4103/1673-5374.239432. PMID: 30233054; PMCID: PMC6183038. 

Gill S, Santo J, Blair M, Morrow SA. Depressive Symptoms Are Associated With More Negative Functional Outcomes Than Anxiety Symptoms in Persons With Multiple Sclerosis. J Neuropsychiatry Clin Neurosci. 2019 Winter;31(1):37-42. doi: 10.1176/appi.neuropsych.18010011. Epub 2018 Sep 6. PMID: 30187820.

DiGiuseppe G, Blair M, Morrow SA. Short Report: Prevalence of Cognitive Impairment in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis. Int J MS Care. 2018 Jul-Aug;20(4):153-157. doi: 10.7224/1537-2073.2017-029. PMID: 30150898; PMCID: PMC6107340.

Kim DD, Ho C, King R, Morrow SA. Pearls & Oy-sters: An unusual neuropsychiatric manifestation of systemic lupus erythematosus. Neurology. 2018 May 22;90(21):e1929-e1932. doi: 10.1212/WNL.0000000000005555. PMID: 29784725.

Oh J, Gagné-Brosseau MS, Guenette M, Larochelle C, Lemieux F, Menon S, Morrow SA, Poliquin-Lasnier L, Roy-Hewitson C, Rush C, Trudelle AM, Giacomini PS. Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner. Can J Neurol Sci. 2018 May;45(3):304-312. doi: 10.1017/cjn.2018.7. PMID: 29756588.

Grand'Maison F, Yeung M, Morrow SA, Lee L, Emond F, Ward BJ, Laneuville P, Schecter R. Sequencing of disease-modifying therapies for relapsing-remitting multiple sclerosis: a theoretical approach to optimizing treatment. Curr Med Res Opin. 2018 Aug;34(8):1419-1430. doi: 10.1080/03007995.2018.1458023. Epub 2018 Apr 18. PMID: 29583054. 

Morrow SA, Fraser JA, Day C, Bowman D, Rosehart H, Kremenchutzky M, Nicolle M. Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial. JAMA Neurol. 2018 Jun 1;75(6):690-696. doi: 10.1001/jamaneurol.2018.0024. PMID: 29507942; PMCID: PMC5885218.

Morrow SA, Rosehart H, Sener A, Welk B. Anti-cholinergic medications for bladder dysfunction worsen cognition in persons with multiple sclerosis. J Neurol Sci. 2018 Feb 15;385:39-44. doi: 10.1016/j.jns.2017.11.028. Epub 2017 Nov 22. PMID: 29406911.

Morrow SA. Anxiety is more important than depression in MS - Yes. Mult Scler. 2018 Apr;24(4):440-441. doi: 10.1177/1352458517751652. Epub 2018 Jan 30. PMID: 29381115.

Members of the MS in the 21st Century Steering Group:, Rieckmann P, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Kesselring J, Kobelt G, Langdon D, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, Thompson H, Vermersch P, Aston K, Bauer B, Demory C, Giambastiani MP, Hlavacova J, Nouvet-Gire J, Pepper G, Pontaga M, Rogan E, Rogalski C, van Galen P, Ben-Amor AF. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group. Mult Scler Relat Disord. 2018 Jan;19:153-160. doi: 10.1016/j.msard.2017.11.013. Epub 2017 Nov 21. PMID: 29241142.

Morrow SA, Classen S, Monahan M, Danter T, Taylor R, Krasniuk S, Rosehart H, He W. On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: A prospective study. Mult Scler. 2018 Oct;24(11):1499-1506. doi: 10.1177/1352458517723991. Epub 2017 Aug 7. PMID: 28782411. 

Classen S, Krasniuk S, Morrow SA, Alvarez L, Monahan M, Danter T, Rosehart H. Visual Correlates of Fitness to Drive in Adults With Multiple Sclerosis. OTJR (Thorofare N J). 2018 Jan;38(1):15-27. doi: 10.1177/1539449217718841. Epub 2017 Aug 2. PMID: 28766462.

Fakolade A, Lamarre J, Latimer-Cheung A, Parsons T, Morrow SA, Finlayson M. Understanding leisure-time physical activity: Voices of people with MS who have moderate-to-severe disability and their family caregivers. Health Expect. 2018 Feb;21(1):181-191. doi: 10.1111/hex.12600. Epub 2017 Jul 19. PMID: 28722772; PMCID: PMC5750693.

Berger W, Payne MWC, Morrow SA. Self-reported maximum walking distance in persons with MS may affect the EDSS. J Neurol Sci. 2017 Aug 15;379:77-80. doi: 10.1016/j.jns.2017.05.035. Epub 2017 May 17. PMID: 28716284.

Welk B, McArthur E, Ordon M, Morrow SA, Hayward J, Dixon S. The risk of dementia with the use of 5 alpha reductase inhibitors.J Neurol Sci. 2017 Aug 15;379:109-111. doi: 10.1016/j.jns.2017.05.064. Epub 2017 May 31. PubMed PMID: 28716218.

Berger W, Payne MWC, Morrow SA. Self-reported maximum walking distance in persons with MS may affect the EDSS. J Neurol Sci. 2017 Aug 15;379:77-80. doi: 10.1016/j.jns.2017.05.035. Epub 2017 May 17. PubMed PMID: 28716284

Classen S, Krasniuk S, Morrow SA, Alvarez L, Monahan M, Danter T, Rosehart H. Visual Correlates of Fitness to Drive in Adults With Multiple Sclerosis. OTJR (Thorofare N J). 2017 Aug 1:1539449217718841. doi: 10.1177/1539449217718841. [Epub ahead of print] PubMed PMID: 28766462.

Morrow SA, Classen S, Monahan M, Danter T, Taylor R, Krasniuk S, Rosehart H, He W. On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: A prospective study. Mult Scler. 2017 Aug 1:1352458517723991. doi: 10.1177/1352458517723991. [Epub ahead of print] PubMed PMID: 28782411.

Fakolade A, Lamarre J, Latimer-Cheung A, Parsons T, Morrow SA, Finlayson M. Understanding leisure-time physical activity: Voices of people with MS who have moderate-to-severe disability and their family caregivers. Health Expect. 2017 Jul 19. doi: 10.1111/hex.12600. [Epub ahead of print] PubMed PMID: 28722772

Walker LAS, Marino D, Berard JA, Feinstein A, Morrow SA, Cousineau D. Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple Sclerosis. Can J Neurol Sci. 2017 Jul 7:1-9. doi: 10.1017/cjn.2017.199. [Epub ahead of print] PubMed PMID: 28683843.

Krasniuk S, Classen S, Morrow SA, Monahan M, Danter T, Rosehart H, He W. Driving Errors That Predict On-Road Outcomes in Adults With Multiple Sclerosis. OTJR (Thorofare N J). 2017 May 1:1539449217708554. doi: 10.1177/1539449217708554. [Epub ahead of print] PMID: 28539098

Morrow SA, Menon S, Rosehart H, Sharma M. Developing easy to perform routine MRI measurements as potential surrogates for cognitive impairment in MS. Clin Neurol Neurosurg. 2017 Feb;153:73-78. doi: 10.1016/j.clineuro.2016.12.015. Epub 2016 Dec 29. PMID: 28061362

Hanna J, Santo JB, Blair M, Smolewska K, Warriner E, Morrow SA. Comparing depression screening tools in persons with multiple sclerosis (MS). Rehabil Psychol. 2017 Feb;62(1):20-24. doi: 10.1037/rep0000115. Epub 2016 Dec 5. PMID: 27918176

Morrow SA, Rosehart H, Johnson AM. The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS. Mult Scler Relat Disord. 2017 Jan;11:4-9. doi: 10.1016/j.msard.2016.10.011. Epub 2016 Nov 4. PMID: 28104253

Classen S, Krasniuk S, Alvarez L, Monahan M, Morrow SA, Danter T. Development and Validity of Western University's On-Road Assessment. OTJR (Thorofare N J). 2017 Jan;37(1):14-29. doi: 10.1177/1539449216672859. Epub 2016 Oct 15. PMID: 27744272

News


Social Media Coverage